logo-loader
Kanabo Research

Kanabo Research sets sights on London listing

Israeli-based Kanabo Research could become the first cannabis firm to list on the main market of the London Stock Exchange.
The company, which has developed a vaporiser for the inhalation of medical cannabis, is planning to list through a reverse takeover by cash shell Spinnaker Opportunities.
Spinnaker has signed a head of terms to buy Kanabo and the deal is waiting on UK approval.
Chief executive Avihu Tamir sat down with Proactive’s Andrew Scott to talk about the deal and Kanabo's move towards the commercialisation of its VapePod device.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Zena Pay looks to help cannabis industry navigate the...

Fig House communication’s Dave Carter joined Steve Darling from Proactive Vancouver to discuss Zena Pay. They provide software solutions that specialize in payment, plant tracking, cannabis business management software, supply chain management, compliance management and government auditing...

2 days ago

2 min read